Grant: Alliance Grants
University of Calgary
$50,000.00
Surface plasmon resonance spectroscopy for characterization of COVID-19 biosensors_x000d_ _x000d_ _x000d_
EF 2020-21
Résumé
Motivation. There is a critical technological gap in reliable, very rapid, and robust detection of coronaviruses, including COVID-19. Electrochemical-based sensing methods are appealing for clinical diagnostics, due to simplicity, fast response, minimum label requirement, and low cost. Binding of target cDNAs and RNAs to DNA probes immobilized on the electrode causes changes in the mass transfer of redox species and alters electrical currents. There are still factors affecting biosensors' clinical performance that have not been systematically investigated. Surface plasmon resonance (SPR) spectroscopy is a commonly used technique for biosensor characterization and for determining binding affinity between target analytes and surface-immobilized biorecognition probes. SPR can potentially be used to differentiate between non-specific binding of random targets to the biorecognition probe and non-specific adsorption of matrix contaminants on the monolayer.
Aims. The objective of the proposed project is to develop and validate DNA probes with high affinity and specificity to viral RNA of SARS-CoV-2. At the end of this project, effective DNA probes and new electrochemical sensing protocols will be developed, which will be applicable in electrochemical biosensors for the rapid diagnosis of COVID-19. Aim #1: SPR-based bio-affinity analysis of DNA probes and target molecules. Aim #2: Electrochemical DNA biosensor development using optimized DNA probes developed in #Aim 1.
Impact. The DNA probes developed and validated using the SPR technology of the partner will be used by electrochemical biosensors for the rapid diagnosis of SARS-CoV-2 in Canada. The DNA probes and biosensing protocols developed in this project will contribute to implementing new testing and production strategies to increase the quality control of the next generation of electrochemical biosensors and diagnostic tools.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
553517-2020
Name nom
Sanati Nezhad, Amir
Department département
Mechanical and Manufacturing Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Surface plasmon resonance spectroscopy for characterization of COVID-19 biosensors_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
Motivation. There is a critical technological gap in reliable, very rapid, and robust detection of coronaviruses, including COVID-19. Electrochemical-based sensing methods are appealing for clinical diagnostics, due to simplicity, fast response, minimum label requirement, and low cost. Binding of target cDNAs and RNAs to DNA probes immobilized on the electrode causes changes in the mass transfer of redox species and alters electrical currents. There are still factors affecting biosensors' clinical performance that have not been systematically investigated. Surface plasmon resonance (SPR) spectroscopy is a commonly used technique for biosensor characterization and for determining binding affinity between target analytes and surface-immobilized biorecognition probes. SPR can potentially be used to differentiate between non-specific binding of random targets to the biorecognition probe and non-specific adsorption of matrix contaminants on the monolayer.
Aims. The objective of the proposed project is to develop and validate DNA probes with high affinity and specificity to viral RNA of SARS-CoV-2. At the end of this project, effective DNA probes and new electrochemical sensing protocols will be developed, which will be applicable in electrochemical biosensors for the rapid diagnosis of COVID-19. Aim #1: SPR-based bio-affinity analysis of DNA probes and target molecules. Aim #2: Electrochemical DNA biosensor development using optimized DNA probes developed in #Aim 1.
Impact. The DNA probes developed and validated using the SPR technology of the partner will be used by electrochemical biosensors for the rapid diagnosis of SARS-CoV-2 in Canada. The DNA probes and biosensing protocols developed in this project will contribute to implementing new testing and production strategies to increase the quality control of the next generation of electrochemical biosensors and diagnostic tools.